Main Menu
- Home
- About Us
- About Clinical Immunology and Allergy
- About ASCIA e-training
- AIFA
- ASCIA Collaborations
- ASCIA Education Projects
- ASCIA Highlights
- ASCIA History 1990 to 2024
- ASCIA Initiatives
- ASCIA Sustainability 2020 to 2022
- Disclaimer and Privacy
- Information updates
- Change to My Health Record COVID-19 Pathology Reports
- Australia Day 2021 Honours for ASCIA Members
- New ASCIA Quick Reference Guides for COVID-19 Vaccination
- Signs and Symptoms of Allergic Reactions
- ASCIA and WAO COVID-19 vaccine updates
- ASCIA 2021 Conference Update
- PBS listing of Dupixent (dupilumab) for severe atopic dermatitis
- Anapen® is TGA approved and recommended by PBAC for PBS Listing
- International Women's Day
- New and Updated ASCIA COVID-19 Vaccine FAQs
- Updated and New ASCIA Information about Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments
- Virtual Meetings about COVID-19 Vaccines
- PBS listings of Dupixent (dupilumab) for uncontrolled severe asthma (1st April 2021) and severe atopic dermatitis (1st March 2021)
- New Animation - How to Safely Remove Ticks
- Updated ASCIA COVID-19 resources
- New ASCIA Oral Immunotherapy for Food Allergy information
- New Animation - How to Position a Person having Anaphylaxis
- Immunoglobulin (Ig) Program Update
- ASCIA 2021 Virtual Conference Registration and Abstract Submission is Now Open
- Updated ASCIA Action Plans
- Updated ASCIA Action Plan for Drug (Medication) Allergy
- World Allergy Week 2021
- ASCIA Online Resources Update - June 2021
- ASCIA 2021 Virtual Conference - Updated Program
- New ASCIA Eosinophilic Oesophagitis (EoE) Resources - July 2021
- New and updated ASCIA COVID-19 vaccination resources - July 2021
- Updated ASCIA Sulfite Sensitivity information - July 2021
- New ASCIA Anaphylaxis Refresher e-training - August 2021
- ASCIA First Aid Plan for Anaphylaxis 2021 Pictorial
- Update – Allergies and Anaphylaxis Parliamentary Inquiry
- Anapen® Patient Support
- MyEpiPen® Patient Support Program
- RACP Awards and Medals
- ASCIA 2021 Virtual Conference Update
- Updated ASCIA COVID-19 Information
- Updated ASCIA anaphylaxis resources
- Updated ASCIA eczema resources
- COVID-19 vaccination digital certificates
- New allergy guidelines for schools and children's education/care
- Third COVID-19 vaccine dose recommended for people who are severely immunocompromised
- National Allergy Strategy Updates
- Approval for COVID-19 vaccine booster doses
- COVID-19 Vaccination Update
- New Anaphylaxis Clinical Care Standard
- Parliamentary Inquiry Report
- New ASCIA Chronic Rhinosinusitis Position Paper
- ASCIA Food Allergy e-training
- ASCIA General Action and First Aid Plans for Anaphylaxis now include QR codes
- ASCIA's Plans for 2022
- Responding to an anaphylaxis emergency when there is limited access to an ambulance
- COVID-19 vaccines are safe for people with allergies, including children
- Updated ASCIA Adrenaline Injector Prescribing Guidelines and FAQ - January 2022
- Updated and new ASCIA HAE resources - January 2022
- PBS listing of RINVOQ® (upadacitinib) for severe atopic dermatitis - February 2022
- COVID-19, allergy and asthma
- Updated ASCIA COVID-19 vaccination FAQ
- ACTAIR® TGA paediatric approval extended
- Walking the Allergy Tightrope
- Abbott infant formula recall
- New ASCIA Chronic Urticaria FAQ - February 2022
- Nutricia allergy formula supply issues - February 2022
- Allergen Immunotherapy Symposium 17th March 2022
- New allergy prevention study
- AAAAI Highlights Webinar 23rd March 2022
- New ASCIA anaphylaxis refresher e-training for health professionals
- Updated ASCIA Guide - Milk Substitutes in Cow’s Milk Allergy
- New Nip allergies in the Bub infant feeding videos
- My Health Record Webinar for ASCIA members 31 March 2022
- Updated ASCIA Eczema Resources
- Novalac Allergy Infant Formula Update
- Evusheld for COVID-19 prophylaxis
- New ASCIA food allergen challenge resources - April 2022
- New ASCIA antibiotic allergy challenge resources - April 2022
- New and updated ASCIA anaphylaxis resources - April 2022
- Changes to IVIg supply - April 2022
- ASCIA Immunodeficiency Strategy launch - April 2022
- A $10 screening test could have helped my ‘bubble’ baby
- IFNAR1 deficiency and vaccines - May 2022
- Allergic diseases and anaphylaxis funding announced in Federal Budget -March 2022
- Paxlovid® is PBS listed for treatment of COVID-19 - May 2022
- HAE Day - Monday 16 May 2022
- Jorveza® is PBS listed for treatment of EoE - May 2022
- Support for people with primary immunodeficiencies - May 2022
- Influenza vaccination and allergy - May 2022
- Autoinflammatory Disease Symposium - June 2022
- World Allergy Week - 5 to 11 June 2022
- CFAR Hot Publications call for submissions - June 2022
- Telehealth Update - July 2022
- ASCIA 2022 Conference Update - July 2022
- SCID Newborn Screening Update - July 2022
- ASCIA 2022 Conference Health and Safety Measures - July 2022
- ASCIA 2022 Conference Registration is still open - July 2022
- New ASCIA Radiocontrast Media Position Statement - July 2022
- New Food Allergy Course for Residential Care - August 2022
- Improved access to ASCIA website information - August 2022
- Launch of National Allergy Council and National Allergy Centre of Excellence - August 2022
- Anapen® now approved for 3 seconds - September 2022
- ASCIA 2022 Conference Report - September 2022
- ASCIA AGM - September 2022
- AIFA 2022 research grants announced - September 2022
- ASCIA website - major update October 2022
- New ASCIA anaphylaxis translations webpage - October 2022
- ASCIA Dietary Guides - now with ReadSpeaker - October 2022
- Links to animations on ASCIA website - January 2023
- Allergic reactions to dental products containing Recaldent - December 2022
- Pharmac to fund EpiPen for severe allergies from February 2023
- Voluntary recall of specific batches of ALK Peanut SPT in Australia - December 2022
- ASCIA Food Allergy and Adverse Food Reactions Course for Dietitians
- Donate to AIFA and make a difference to allergy and immunology research - December 2022
- PBAC Meeting March 2023
- Immunoglobulin Governance Program Updates - January 2023
- CHOICE Allergen Immunotherapy study
- Nominations for National Allergy Council - January 2023
- ASCIA Progress Report - National Allergy Council Shared Care for Allergy project - February 2023
- ASCIA Progress Report - National Allergy Council Schools and Childcare project - February 2023
- ASCIA e-training feedback surveys - February 2023
- ASCIA events in World Primary Immunodeficiency Week - 22-29 April 2023
- Guideline for Pharmacological Management of Inflammatory Arthritis - Submissions due 30 April 2023
- ASCIA Food Allergy and Adverse Food Reactions Course
- AIFA Research Grants - EOIs due 5 May 2023
- Shared Care for Allergy consultation meetings - May and June 2023
- Nucala® (mepolizumab) PBS listed for CRSwNP - April 2023
- Updated ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy - April 2023
- New ASCIA Penicillin Allergy FAQ - April 2023
- Updated ASCIA IVIg Infusion Guidelines - April 2023
- Updated ASCIA OIT for Food Allergy Position Paper - April 2023
- World Primary Immunodeficiency Week 22-29 April 2023
- ASCIA Immunodeficiency Strategy Priorities
- Registration is still open for ASCIA 2023 Conference - May 2023
- ASCIA Progress Report – National Allergy Council Projects - May 2023
- New and Updated ASCIA Fast Facts - June 2023
- Alfamino® Formula for Infants with Cow's Milk Allergy - July 2023
- ASCIA Progress Report - NAC Schools and CEC Project - July 2023
- ASCIA Progress Report - NAC Shared Care for Allergy Project - July 2023
- Venom Immunotherapy Practice Survey - July 2023
- Transition from Evogam to Hizentra AU SCIg products - July 2023
- ASCIA Survey to improve undergraduate allergy education for health professionals - August 2023
- Australian Quality Standard for Rheumatoid Arthritis - August 2023
- New Subcutaneous Immunoglobulin (SCIg) products - August 2023
- ASCIA 2023 Conference Report - September 2023
- New ASCIA Management Plan for Delayed Allergic Reactions to Foods - September 2023
- AusPollen partnership impact case study published by NHMRC - September 2023
- ACECQA approved ASCIA anaphylaxis e-training for children's education and care services - October 2023
- Undergraduate Allergy Training for Health Professionals Survey - Closing date 17 February 2024
- Shingrix Vaccine to Prevent Shingles - September 2024 Update
- ASCIA Food Allergy and Adverse Food Reactions Course for Dietitians in Sydney 23rd-24th November 2023
- Changes to PBS Criteria - Jorveza EoE treatment - November 2023
- ASCIA Update – Shared Care Project - November 2023
- ATAGI COVID-19 Vaccine Recommendations - December 2023
- Updated ASCIA Dietary Avoidance for Food Allergy FAQ - December 2023
- Updated Guidelines for Anaphylaxis Prevention and Management - December 2023
- Red Imported Fire Ants in Australia - Senate Inquiry - Submissions due 29 January 2024
- Edible Insect Food Allergy Survey - Closing date 9 February 2024
- NBA SCIg Report - December 2023
- New Format for ASCIA E-newsletters
- Arexvy® RSV Vaccine
- PBAC Meeting March 2024 - ASCIA Submissions
- Updated ASCIA Adrenaline Injectors FAQ
- New ASCIA Newborn Screening Resources
- Latest Versions of ASCIA Action Plans for Anaphylaxis - February 2024 Update
- Recent National Allergy Council Updates
- Quicklinks to QR codes on ASCIA patient/carer information webpages
- ASCIA Annual Conference and AIFA Research Grant Sponsorship
- AIFA 2024 Research Grant Round Open - EOIs due 14 May 2024
- Recent ASCIA Updates – Anaphylaxis and Allergy
- Recent ASCIA Updates – Immunodeficiency and Autoimmunity
- New ASCIA Mast Cell Activation Disorders and Syndrome Position Paper
- ASCIA 2024 Conference registration is still open
- ASCIA Anaphylaxis e-training for Health Professionals Reports
- ASCIA Anaphylaxis e-training for Schools and Childcare Reports
- Food Allergy Week 2024 - When eating out, always ask, always tell
- Updates to Australian medicine labelling rules to support medicine safety
- ASI Clinical Translation School 2024
- Product Update - Anapen® Adrenaline (Epinephrine) Injector Devices
- Allergic reactions to Andrographis paniculata
- Saphnelo (anifrolumab) listed on the PBS for patients with severe SLE - 1 July 2024
- Updated ASCIA Adrenaline Device PBS Authority Form
- Alfaré® infant formula to be deleted from PBS - 1 August 2024
- TGA Consultation - Proposed Reforms to Therapeutic Goods Regulations
- New Australian Hereditary Angioedema (HAE) publication
- Activity based funding for subcutaneous immunoglobulin (SCIg) therapy
- ASCIA application for MBS item for supervised oral food challenges
- ASCIA Annual General Meeting 2024
- New peanut allergy treatment program for babies in Australia
- New ASCIA Clinical Care Standard for inborn errors of immunity / primary immunodeficiencies
- Inaugural ASCIA meeting for heads of allergy/immunology departments
- Recent ASCIA Website Updates - Anaphylaxis and Allergy
- Recent ASCIA Website Updates - Immunodeficiency and Autoimmunity
- New ASCIA Infographic - How to position a person when adrenaline is given
- ASCIA Quicklinks improve access to ASCIA information
- Health Professional Allergy Education and Training Initiatives
- ASCIA 2024 Conference Report
- Updated ASCIA OIT for Food Allergy FAQ
- Biologics in Severe Asthma - Change in PBS Criteria - October 2024
- New PBS Listed Treatment for ANCA Associated Vasculitis - October 2024
- Vale Dr Rob Loblay MBBS PhD FRACP - October 2024
- Vale A/Prof Dan Czarny MBBS FRACP FRCP - May 2024
- ASCIA Submission - RACP Clinical Immunology and Allergy Advanced Training Curriculum - October 2024
- ASCIA Quicklinks Update
- Consultations Currently Open for Feedback
- AIFA Research Grants 2024
- ASCIA Highlights 2023-2024
- Research Opportunity: Allergic Rhinitis QUT Survey - Responses due 30 November 2024
- ASCIA Participation in Medical Conferences 2024
- Global Collaborative Online Allergy Symposium - 17 January 2025
- ASCIA 2025 Conference Sponsorship Prospectus
- ASCIA Action Plans for Anaphylaxis - 2025 versions
- National Allergy Council projects allocated to ASCIA - November 2024 Update
- Links
- Online payments
- Quicklinks
- Sponsors
- ASCIA Update Newsletter
- Website Information
- National Allergy Strategy
- World Allergy Organization
- World Allergy Week
- Sitemap
- Members
- ASCIA Annual General Meeting
- ASCIA Committees and Working Parties
- ASCIA Constitution
- ASCIA Past Presidents
- ASCIA Member access to SPT reagents
- ASCIA Member allergen immunotherapy information
- ASCIA Member feedback
- ASCIA Membership applications
- ASCIA Membership fee payment
- Medical Product Supply Updates
- Positions
- ASCIA Website - member access
- ASCIA Medical Associates
- Dietitians
- Nurses
- Scientists
- Adrenaline injector availability
- ASCIA Annual Reports
- ASCIA Penicillin allergy guidelines
- ASCIA ID Register Access Film
- Insect Allergy
- ASCIA Member Publications
- ASCIA 2016 Conference Photographs
- ASCIA 2015 Conference Photographs
- ASCIA 2012 Conference Photographs
- ASCIA 2011 Conference Photographs
- Health Professionals
- Resources for HPs
- ASCIA Clinical Update Allergic Rhinitis
- ASCIA References Allergic Rhinitis
- ASCIA Position Paper - Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- ASCIA References CRSwNP A-L
- ASCIA References CRSwNP M-Z
- ASCIA Guidelines Acute management of anaphylaxis
- ASCIA Guidelines Acute Management of Anaphylaxis in Pregnancy
- ASCIA Guidelines for the prevention of anaphylaxis in schools, preschools and childcare
- ASCIA Anaphylaxis References
- ASCIA Clinical Update Antibiotic Allergy
- ASCIA References: Drug (Penicillin) Allergy References
- ASCIA References: Drug (Cephalosporin) Allergy
- ASCIA Penicillin Allergy Guide for health professionals
- ASCIA Position Paper - Diagnosis and Investigation of Mast Cell Activation Disorders and Syndrome
- ASCIA Position Paper Food Allergen Challenges
- ASCIA Consent Form - Food Allergen Challenges
- ASCIA Position Paper Oral Immunotherapy (OIT) for Food Allergy
- ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy
- Lupin food allergy
- Immunodeficiency and Autoimmunity
- ASCIA Position Statement - COVID-19 Prophylaxis in People with Immune Deficiencies
- ASCIA Position Statement - Immunoglobulin Replacement Therapy in PID
- ASCIA Guidelines SCID TAPID
- ASCIA Inborn Errors of Immunity (Primary Immunodeficiencies) Clinical Care Standard
- ASCIA Newborn Screening for SCID and BCG Vaccination Position Statement
- Hereditary Angioedema
- ASCIA PID Clinical Update
- Immunodeficiency References
- Hereditary Angioedema (HAE) References
- Subcutaneous Immunoglobulin (SCIg)
- ASCIA SCIg Treatment Plan
- ASCIA Transfer Care Plan - IRT
- ASCIA Travel Plan for SCIg Patients
- ASCIA SCIg Competency Training Checklists
- Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital
- ASCIA Guidelines for standardised IVIg infusion rates for IRT
- ASCIA Guidelines: Vaccination of the egg-allergic individual
- ASCIA SCIT Treatment Plan
- ASCIA SLIT Treatment Plan
- ASCIA Venom Immunology Guide
- ASCIA Aeroallergen Immunology Guide
- Infant feeding and allergy prevention
- ASCIA Position Statement - Commercial Infant Feeding Products Containing Multiple Common Food Allergens
- ASCIA Clinical Update Infant Feeding and Allergy Prevention
- ASCIA Guidelines for infant feeding and allergy prevention
- ASCIA Stepwise Management Plan for Eczema
- ASCIA Guide to peanut introduction
- ASCIA References for infant feeding | allergy prevention
- Jack Jumper Ant Venom Immunotherapy
- Jack Jumper Ant Allergy - a uniquely Australian problem
- Management of Latex-allergic Patients
- Chronic Spontaneous Urticaria (CSU) Guidelines
- ASCIA References Chronic Urticaria
- ASCIA References Food Allergy
- ASCIA References Food Allergen Challenges
- ASCIA References OIT for Food Allergy
- Position Paper: Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments
- Refs: Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments
- Allergen immunotherapy availability
- Specific allergen immunotherapy for asthma
- External position papers
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
- International position papers and guidelines
- Skin prick testing
- Tests in the Diagnosis of Allergic Diseases
- Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool
- Anaphylaxis Resources
- ASCIA Action Plan: Anaphylaxis
- ASCIA Travel Plan: Anaphylaxis
- ASCIA Action Plans Frequently Asked Questions
- Anaphylaxis Checklist for GPs
- Anaphylaxis Checklist for Pharmacists
- ASCIA Management Summary for Allergic Conditions
- Anaphylaxis Guidelines
- Anaphylaxis Event Record
- Signs and Symptoms of Allergic Reactions
- How to position a person having anaphylaxis
- Clinical History Form - allergic reactions
- First Aid for Anaphylaxis
- First Aid for Anaphylaxis Pictorial Poster
- First Aid Other Languages
- First Aid Languages - New Zealand
- Fact Sheet for Parents Anaphylaxis - New Zealand
- ASCIA Adrenaline Device Authority Form
- ASCIA Guidelines for adrenaline injector prescription
- Adrenaline injectors||General use
- Adrenaline injectors||Storage, expiry, disposal
- Adrenaline injectors
- EpiPen® Jr Out of Stock
- How to give Epipen
- How to give Anapen
- How to give injector
- How to give Epipen||Languages New Zealand
- How to give Epipen||Other Languages
- Translations of anaphylaxis information
- How to give Emerade
- Drug allergy
- Food Allergy
- Food – Other Adverse Reactions
- Respiratory Allergy - Allergic Rhinitis (Hay Fever), Asthma and Sinusitis
- Venom Allergy
- Other Allergy
- Allergen Immunotherapy
- Allergy Prevention
- Allergy Testing
- Skin
- Autoimmunity
- Laboratory Tests for Autoimmune Diseases
- Immunisation
- External Links
- ASCIA Action, First Aid, Management, Transfer, Travel and Treatment Plans
- Health Professionals e-training
- ASCIA allergy and anaphylaxis e-training
- ASCIA allergen immunotherapy e-training for health professionals
- ASCIA immunodeficiency e-training for health professionals
- ASCIA e-training for pharmacists
- ASCIA e-training for health professionals
- ASCIA food allergy e-training
- Anaphylaxis - short film
- HP e-training feedback
- Podcast - Antibiotics and Allergy
- Webinar - Immunodeficiency
- A career in Clinical Immunology and Allergy
- Awards/Grants
- Research Studies
- Resources for HPs
- Patients
- Allergy and Clinical Immunology Services
- Locate a specialist
- Patient support organisations
- Anaphylaxis e-training
- Anaphylaxis e-training first aid (community)
- Fast Facts
- Adrenaline (Epinephrine) Injectors
- Allergic Rhinitis (Hay Fever )
- Allergy Testing
- Allergy Treatments
- Anaphylaxis
- Asthma and Allergy
- Autoimmune Diseases
- Cow’s Milk (Dairy) Allergy
- Drug (Medication) Allergy
- Eczema (Atopic Dermatitis)
- Eczema and Food Allergy
- Evidence-based Allergy Tests and Treatments
- Food Allergy
- Immune System
- Immunodeficiencies
- Infant Feeding and Allergy Prevention
- Insect and Tick Allergy
- Peanut Allergy
- Seed Allergy
- Tree Nut Allergy
- Allergy and anaphylaxis
- Allergic rhinitis (hay fever) and sinusitis
- Allergic rhinitis (hay fever)
- Allergic Rhinitis Treatment Plan
- Allergic conjunctivitis
- Nasal polyps
- Non-Allergic Rhinitis
- Pollen allergy
- Pollen calendar - guide to common allergenic pollen
- Bermuda/Couch Grass
- Annual Blue / Winter Grass
- Ryegrass
- Kentucky Blue/June Grass
- Cocksfoot/Orchard Grass
- Yorkshire Fog/Velvet Grass
- Canary Grass
- Wild Oat
- Timothy Grass
- Bahia Grass
- Johnson Grass
- Plantain
- Paterson`s curse/Salvation Jane
- Pellitory/Asthma weed
- Ragweed
- Parthenium Weed
- English Oak
- Silver birch
- Australian Pine/She Oak
- Murray Pine/ White Cypress Pine
- London Plane Tree
- Olive Tree
- Bottlebrush
- Paper-bark Tea Tree
- Mango Tree
- Sinusitis and allergy
- Vocal Cord Dysfunction
- Allergy and the skin
- Allergy prevention
- Allergy testing
- Allergy treatments
- Asthma and allergy
- Autoimmunity
- Drug allergy
- Food allergy
- ASCIA Dietary avoidance for food allergy
- ASCIA Dietary avoidance for food allergy FAQ
- Allergic and toxic reactions to seafood
- Coconut allergy
- Cow`s milk (dairy) allergy
- Egg allergy flu vaccine
- Food Allergy FAQ
- Lupin food allergy
- Mammalian meat and tick allergy
- Peanut, tree nut and seed allergy
- Wheat Dependant Exercise Induced Anaphylaxis
- Food other adverse reactions
- Food intolerance
- Lactose Intolerance
- Milk, mucus and cough
- Oral Allergy Syndrome
- Eosinophilic Oesophagitis (EoE)
- Two Food Elimination Diet (2FED) for EoE
- Four Food Elimination Diet (4FED) for EoE
- Action Plan for Eosinophilic Oesophagitis (EoE)
- Management Plan for Eosinophilic Oesophagitis (EoE)
- Food Protein Induced Enterocolitis Syndrome (FPIES)
- FPIES Action Plan
- Food Protein-Induced Allergic Proctocolitis (FPIAP)
- Management Plan for Delayed Allergic Reactions to Foods
- Immune system
- Immunisation
- Immunodeficiencies
- Subcutaneous immunoglobulin (SCIg) therapy - general information
- Subcutaneous immunoglobulin (SCIg) therapy - equipment checklist
- Subcutaneous immunoglobulin (SCIg) infusion checklist
- Immunoglobulin replacement therapy
- Primary Immunodeficiency (PID)
- Severe combined immunodeficiency
- Newborn Screening for Severe Combined Immune Deficiency (SCID)
- Common variable immune deficiency (CVID)
- Hereditary Angioedema (HAE)
- Insect and tick allergy
- Other allergies
- Schools
- Meetings
- Reports
- Submissions
- Telehealth
- Videos
- Search